Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
BMY
GILD
Add up to 3 more stocks
BMY
Bristol-Myers Squibb Company
-0.17%
$63.64-0.11Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$130.00B
52W Range
$42.52 - $68.64
GILD
Gilead Sciences, Inc.
-0.75%
$143.72-1.09Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$178.44B
52W Range
$108.46 - $157.29
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 14.02 | N/A |
| Forward P/E | 9.18 | N/A |
| P/B Ratio | 5.82 | 15.09 |
| P/S Ratio | 2.64 | 5.86 |
| P/FCF Ratio | 11.36 | 13.76 |
| EV/EBITDA | 9.71 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 70.2% | 79.6% |
| Operating Margin | 28.3% | 39.7% |
| Net Margin | 18.9% | -10.6% |
| ROE | 41.6% | -27.4% |
| ROA | 10.6% | -6.6% |
| ROIC | 15.5% | -3.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.53 | 1.27 |
| Quick Ratio | 1.38 | 1.09 |
| Debt/Equity | 1.93 | 2.22 |
| Interest Coverage | 7.26 | 11.43 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 3.9% | 2.2% |
| Payout Ratio | 55.3% | N/A |
| Yrs of Dividend Growth | 16 | 10 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.